Stockreport

Fulcrum Therapeutics (NASDAQ:FULC) shareholders have endured a 77% loss from investing in the stock three years ago [Yahoo! Finance]

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF But that doesn't change the fact that the returns over the last three years have been stomach churning. The share price has sunk like a leaky ship, down 77% in that time [Read more]